P01 Audit of labinic probiotics on the neonatal unit
Authors: Gaze Sian , Ahmad Fuad Umair 
Published: April 2023

BackgroundOur neonatal unit was reviewed by the GIRFT team (Getting It Right First Time) in 2019. One of the recommendations from their report was the introduction of probiotics, to help reduce the incidence of necrotising enterocolitis (NEC). NEC is a devastating illness, which contributes to significant morbidity and mortality in the neonatal population. A variety of probiotics were assessed for safety and clinical efficacy.1–3Labinic was chosen as it contained an optimum combination of probiotic organisms to minimise the risk of NEC developing. In January 2021, Labinic was added to the hospital formulary and Trust guidelines for babies aged < 32 weeks and/or weighing <1.5kg at birth.4AimsTo assess whether premature babies on the neonatal unit were receiving Labinic probiotic drops, as per recently published Trust guidelines.ObjectivesTo identify whether babies were prescribed and administered Labinic at the correct dose, frequency and timing according to the guidance.MethodsA report was run via Badgernet and Medchart to identify patients eligible for inclusion in the study, from January 2021 to October 2021.Inclusion CriteriaPatient was prescribed LabinicPatient was born at our hospitalPatient was born <32 weeks or was born aged 32–36 weeks and weighed <1.5kgBadgernet was used to collect patient-related data:time of the patient’s first feed/colostrumbirth weighttime of deliverylocation of birthMedchart was used to gather data about Labinic prescribing and administration. Patient information was held in a password protected Excel spreadsheet to maintain confidentiality. A pilot data collection form was trialled for 1 week, then adapted. Ethics approval was not required for this study. The audit was registered with the Trust.ResultsData was collected for 76 patients who were prescribed and administered Labinic on the neonatal intensive care unit from January 2021 to October 2021. The mean gestational age of the patients was 28 weeks (23–36 weeks) and the mean weight was 990 grams (500–2200 grams). 76/76 (100%) babies eligible to receive Labinic were prescribed and administered the probiotic. 76/76 (100%) patients were prescribed the correct dose according to their age/weight. The recommendations are that Labinic should be administered either with the first feed or within 12 hours of birth, whichever comes first. Only 17/76 (22%) of infants received Labinic within the first 12 hours.ConclusionsThe introduction of Labinic probiotics has been widely accepted and well implemented on the neonatal unit. Within 2 years of the GIRFT report’s recommendations, the unit has gone from having 0% of eligible patients receiving probiotics to 100% of babies receiving them. Unfortunately, the number of patients included in the study was too low to assess the overall impact on NEC rates. Further education and training will be provided to nursing staff about the importance of administering the first dose of Labinic within the first 12 hours of life. The Trust guidance and electronic prescribing tools will be updated and re-circulated, to highlight that the first dose should be administered within 12 hours, and not delayed until after colostrum or expressed breast milk is available. The audit will be repeated in future to check good practice is maintained and timing of first dose is improved.ReferencesMorelli L, Capurso L. FAO/WHO guidelines on probiotics.Journal of Clinical Gastroenterology2012;46:S1-S2.Allin B, Long A, Gupta A, Knight M, Lakhoo K. A UK wide cohort study describing management and outcomes for infants with surgical necrotising enterocolitis.Scientific Reports2017;7:41149. Available from: http://www.nature.com/articles/srep41149Jin Y, Duan Y, Deng X, Lin J. Prevention of necrotizing enterocolitis in premature infants – an updated review.World Journal of Clinical Pediatrics[Internet] 2019 [cited 20 December 2021];8(2):23–32. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6477149/Probiotics Guidance, Evelina London Children’s Hospital, Guy’s & St Thomas’ NHS Foundation Trust.